abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

Diese Seite ist nicht auf Deutsch verfügbar und wird angezeigt auf English

Artikel

6 Okt 2021

Autor:
Nate Raymond, Reuters

USA: New trial begins against pharmacy chains sued over opioid epidemic

" Pharmacy chains face first trial over U.S. opioid epidemic ", 4 Oct 2021

[In the first trial against four large U.S. pharmacy chains] [t]he Ohio counties … allege that oversight failures at pharmacies run by Walgreens Boots Alliance Inc , CVS Health Corp, Walmart Inc and Giant Eagle Inc led to excessive amounts of opioid pills flooding their communities.

Lawyers for the counties and companies will deliver opening statements to a federal jury in Cleveland, where thousands of similar lawsuits against pharmaceutical companies, drug distributors and pharmacies are pending.

More than 3,300 cases have been brought largely by state and local governments seeking to hold the companies responsible for an opioid abuse epidemic that U.S. government data shows led to nearly 500,000 overdose deaths from 1999 to 2019.

The pharmacy operators deny wrongdoing. CVS said its pharmacies "fill legitimate prescriptions written by licensed doctors."

Walgreens said it took pride in the judgment of its pharmacists, and Giant Eagle said pharmacy inspectors concluded it complied with the law. Walmart did not respond to requests for comment.

Should a jury find the companies liable …[a judge] will determine how much they must pay to abate, or address, the health crisis in the communities. He has urged the parties to settle.

The trial comes after the three largest U.S. distributors that supply pharmacies - McKesson Corp, Cardinal Health Inc and AmerisourceBergen Corp - and the drugmaker Johnson & Johnson in July proposed paying up to $26 billion to settle cases against them.

A bankruptcy judge in August approved a settlement by OxyContin maker Purdue Pharma LP and its wealthy Sackler family owners that the company values at more than $10 billion.

Part of the following timelines

USA: Rise in opioids deaths leads state officials to file claims against drug firms and distributors

USA: Rise in opioids deaths leads state officials to file claims against drug firms and distributors